In 1988, Kiy et al. [10] evaluated the baseline and post-test plasma thyrotropin releasing hormone (TRH) levels of T3 and T4 hormones in patients with PCM and detected low levels of T3 in patients with the acute form of the disease and in those with the severely disseminated chronic form. Here, TRH is linked to paracoccidioidomycosis.